Dauntless Investment Group, LLC - Significant Ownership

Signature - Title
Matthew Okkerse - CFO
Location
Etna, NH
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Dauntless Investment Group, LLC.

Significant Ownership of Dauntless Investment Group, LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
AEON AEON Biopharma, Inc. Common 9.7% $64.9K 108K Dauntless Investment Group, LLC Feb 26, 2025
OKYO OKYO Pharma Ltd Common 5.9% $2.98M 2M Dauntless Investment Group, LLC Mar 12, 2025
FEMY FEMASYS INC Common 5.4% $2M 1.43M Dauntless Investment Group, LLC Feb 18, 2025

Schedules 13D/G Reported by Dauntless Investment Group, LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.